Detalles de la búsqueda
1.
Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide.
Ann Hematol
; 102(6): 1561-1567, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37083956
2.
Allogeneic CD34-selected stem cell boost as salvage treatment of life-threatening infection and severe cytopenias after CAR-T cell therapy.
Transfusion
; 62(10): 2143-2147, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35986653
3.
Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials.
Hematol Oncol
; 39(4): 529-538, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34405901
4.
Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation.
Ann Hematol
; 100(2): 541-553, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33140137
5.
Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH).
Eur J Haematol
; 106(6): 842-850, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33713387
6.
Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease.
J Oncol Pharm Pract
; 27(3): 751-755, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32787560
7.
Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide.
Biol Blood Marrow Transplant
; 26(11): 2089-2097, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32791193
8.
Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?
Ann Hematol
; 97(11): 2089-2098, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29955943
9.
Severe liver toxicity in a chronic myeloid leukemia patient probably induced by a drug interaction between imatinib and sertraline.
J Oncol Pharm Pract
; : 1078155217735689, 2017 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29065786
10.
Digital PCR Improves Sensitivity and Quantification in Monitoring CAR-T Cells in B Cell Lymphoma Patients.
Transplant Cell Ther
; 30(3): 306.e1-306.e12, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38184148
11.
Novel Candidate loci and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing.
Cancers (Basel)
; 15(3)2023 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36765901
12.
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2.
Viruses
; 15(7)2023 06 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37515137
13.
Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/GETH Study.
Transplant Cell Ther
; 29(12): 747.e1-747.e10, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37659694
14.
FLT3-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia.
Cancers (Basel)
; 14(16)2022 Aug 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36010999
15.
Mobile Apps for Hematological Conditions: Review and Content Analysis Using the Mobile App Rating Scale.
JMIR Mhealth Uhealth
; 10(2): e32826, 2022 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35171109
16.
Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: A Meta-Analysis.
Front Oncol
; 12: 882531, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35530329
17.
Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility.
Int J Hematol
; 115(1): 61-68, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34553338
18.
Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel.
Clin Case Rep
; 10(1): e05209, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35028140
19.
Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation.
Front Immunol
; 13: 1002959, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36211438
20.
Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide.
Front Immunol
; 12: 642087, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33841425